• Ziprasidone Hydrochloride (A5350): Mechanisms, Evidence, ...

  2026-03-08

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic and GOT1 inhibitor, validated for both neuropsychiatric and oncology research. This dossier details its serotonin and dopamine receptor antagonist profile, antiproliferative benchmarks, and optimized workflow parameters, establishing a reference for reliable mechanistic and translational studies.

• Ziprasidone HCl: Optimizing Neuroscience and Cancer Resea...

  2026-03-07

  Ziprasidone Hydrochloride (Ziprasidone HCl) uniquely bridges neuroscience and oncology research as a potent serotonin and dopamine receptor antagonist and GOT1 inhibitor. Discover how APExBIO's high-purity formulation accelerates cell-based assays, xenograft models, and translational workflows with robust reproducibility and advanced bioavailability. Streamline your experimental designs with data-driven insights, troubleshooting tips, and the latest formulation innovations.

• Ziprasidone Hydrochloride: A Dual-Action GOT1 Inhibitor f...

  2026-03-06

  Ziprasidone Hydrochloride (Ziprasidone HCl) uniquely bridges neuroscience and oncology by combining potent serotonin/dopamine receptor antagonism with non-competitive GOT1 inhibition. This article delivers actionable protocols, troubleshooting insights, and comparative advantages for researchers leveraging this second-generation antipsychotic agent in both psychotic disorder and cancer models.

• Enhancing Cell-Based Assays with Ziprasidone Hydrochlorid...

  2026-03-06

  This article demonstrates how Ziprasidone Hydrochloride (SKU A5350) addresses core challenges in cell viability and cytotoxicity assays, particularly in cancer and neuroscience workflows. Drawing on recent mechanistic literature, validated protocols, and comparative insights, we highlight the compound’s unique dual-action as a GOT1 inhibitor and serotonin/dopamine receptor antagonist. APExBIO’s rigorously characterized formulation is presented as a reliable, reproducible resource for biomedical researchers.

• Ziprasidone Hydrochloride: Dual-Mechanism Synergy for Tra...

  2026-03-05

  Ziprasidone Hydrochloride (Ziprasidone HCl) has emerged as a uniquely transformative research tool, bridging the worlds of atypical antipsychotic research and next-generation metabolic oncology. This thought-leadership article dissects its dual mechanisms—serotonin/dopamine receptor antagonism and GOT1 inhibition—providing mechanistic insight, experimental guidance, and a strategic roadmap for translational researchers. Integrating new advances in nanocrystal formulation, in vitro and in vivo validation, and future clinical directions, we chart new territory for leveraging Ziprasidone Hydrochloride in interdisciplinary pipelines. APExBIO’s high-quality offering (SKU A5350) anchors this discussion, offering a robust foundation for innovation in both neuroscience and cancer research.

• Ziprasidone Hydrochloride: Dual GOT1 Inhibitor & Antipsyc...

  2026-03-05

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic and potent GOT1 inhibitor, enabling advanced research in both neuroscience and oncology. Its dual action on serotonergic and dopaminergic pathways, plus unique antitumor properties, position it as a versatile tool for translational and cell-based studies.

• Ziprasidone Hydrochloride in Translational Research: Mech...

  2026-03-04

  Ziprasidone Hydrochloride (Ziprasidone HCl, APExBIO SKU A5350) is emerging as a transformative tool for translational researchers, uniquely bridging antipsychotic neuropharmacology and metabolic cancer therapeutics. This article provides a mechanistic deep dive—integrating receptor pharmacology, GOT1-mediated tumor metabolism, and advanced experimental strategies—while charting a visionary framework for leveraging ziprasidone’s dual-action profile in cross-disciplinary pipelines. Drawing on recent in vitro and in vivo evidence, we illuminate how this molecule disrupts pancreatic cancer proliferation and modulates critical neurochemical pathways, distinguishing itself from legacy antipsychotics and conventional GOT1 inhibitors. Strategic recommendations for experimental design, competitive benchmarking, and future translational directions position APExBIO’s Ziprasidone Hydrochloride as an essential asset for next-generation neuroscience and oncology research.

• Ziprasidone Hydrochloride: Applied Workflows for Neurosci...

  2026-03-04

  Ziprasidone Hydrochloride (Ziprasidone HCl) offers unique experimental versatility as both a serotonin and dopamine receptor antagonist and a GOT1 inhibitor, empowering targeted workflows in neuroscience and oncology. This guide delivers practical protocols, data-driven insights, and troubleshooting strategies to maximize reproducibility and scientific rigor, leveraging APExBIO’s trusted supply and quality. Explore advanced applications and actionable tips for accelerating schizophrenia research, psychotic disorder models, and metabolic cancer investigations.

• Reliable Cell Assays with Ziprasidone Hydrochloride (SKU ...

  2026-03-03

  This article delivers a scenario-based, evidence-driven exploration of Ziprasidone Hydrochloride (SKU A5350) for cell viability, proliferation, and cytotoxicity assays. Designed for biomedical researchers and lab technicians, it offers practical guidance rooted in quantitative data, ensuring optimal assay outcomes and reproducibility with APExBIO’s trusted reagent.

• Ziprasidone Hydrochloride (SKU A5350): Optimizing Cell As...

  2026-03-03

  This article provides a scenario-driven, evidence-based guide for biomedical researchers and lab technicians seeking robust, reproducible results in cell viability, proliferation, and cytotoxicity assays using Ziprasidone Hydrochloride (SKU A5350). Explore real-world Q&A addressing assay optimization, compatibility, mechanistic interpretation, and vendor selection, with actionable links to protocols and data for Ziprasidone Hydrochloride.

• Ziprasidone Hydrochloride in Neuroscience and Cancer Rese...

  2026-03-02

  Ziprasidone Hydrochloride (Ziprasidone HCl) bridges neuroscience and cancer research as a dual serotonin and dopamine receptor antagonist with validated GOT1 inhibitory activity. This guide delivers actionable protocols, advanced workflow enhancements, and troubleshooting insights to maximize experimental impact using APExBIO’s rigorously characterized formulation.

• Ziprasidone Hydrochloride (A5350): Dual GOT1 Inhibitor & ...

  2026-03-02

  Ziprasidone Hydrochloride (A5350) is a validated second-generation antipsychotic and GOT1 inhibitor used in neuroscience and cancer research. It exhibits high-affinity antagonism at serotonin and dopamine receptors and disrupts glutamine metabolism in tumor cells, with precise, quantifiable effects in vitro and in vivo.

• Ziprasidone Hydrochloride: A Translational Paradigm for T...

  2026-03-01

  Ziprasidone Hydrochloride (Ziprasidone HCl, A5350) is redefining its role from a second-generation antipsychotic to a multifaceted research tool, bridging neuroscience and oncology. This thought-leadership article provides mechanistic insights and strategic guidance for translational researchers, highlighting Ziprasidone HCl’s dual-action as a serotonin/dopamine receptor antagonist and a GOT1 inhibitor pivotal in pancreatic cancer metabolism. Drawing from landmark studies and validated benchmarks, we map a translational workflow that maximizes the compound’s impact in both psychopharmacology and tumor biology, while projecting future directions for formulation and clinical application.

• Ziprasidone Hydrochloride: Advanced Insights into Dual-Pa...

  2026-02-28

  Explore the multifaceted role of Ziprasidone Hydrochloride as a serotonin and dopamine receptor antagonist and GOT1 inhibitor. This in-depth review uncovers unique mechanistic, formulation, and translational perspectives for neuroscience and oncology research.

• Ziprasidone Hydrochloride in Translational Neuroscience a...

  2026-02-27

  Ziprasidone Hydrochloride stands at the intersection of neuroscience and cancer research, uniquely combining potent serotonin and dopamine receptor antagonism with GOT1 inhibition. This article delivers actionable protocols, advanced workflow enhancements, and troubleshooting strategies to maximize experimental impact with APExBIO’s Ziprasidone HCl (A5350) in both cellular and animal models.

443 records 25/30 page Previous Next First page 上5页 2122232425 下5页 Last page